Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Nov 7:20:2189-98.
doi: 10.12659/MSM.891004.

A meta-analysis of association between cerebral microbleeds and cognitive impairment

Affiliations
Meta-Analysis

A meta-analysis of association between cerebral microbleeds and cognitive impairment

Rihan Wu et al. Med Sci Monit. .

Abstract

Background: The clinical effect of cerebral microbleeds (CMBs) on cognition has been receiving much research attention, but results are often inconsistent.

Material/methods: We searched PubMed, Embase, Web of Science, and some Chinese electronic databases. A total of 15 studies were included.

Results: Patients with CMBs had higher incidence of cognitive dysfunction (OR 3.14; 95% CI 1.66-5.92) and lower scores of cognitive function (SMD was -0.36 [-0.55, -0.18] in the MMSE group and -0.65 [-0.99, -0.32] in the MoCA [Montreal Cognitive Assessment] group). The results also indicated that a higher number of CMB lesions led to more severe cognitive dysfunction (SMD was -2.41 [-5.04, -0.21] in the mild group and -2.75 [-3.50, -2.01] in the severe group). We also found that cognitive performance was significantly impaired when CMBs were located in deep (-0.4 [-0.69, -0.11]), lobar regions (-0.50 [-0.92, -0.09]), basal ganglia (-0.72 [-1.03, -0.41]), and thalamus brain regions (-0.65 [-0.98, -0.32]).

Conclusions: This meta-analysis showed that CMBs were associated with cognitive dysfunction according to higher number and different locations of CMBs. Future work should focus on long-term prognosis of continuing cognitive decline and specific treatments to reduce the formation of CMBs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of search strategy and study selection.
Figure 2
Figure 2
Funnel plots demonstrating that the heterogeneity was not due to publication bias. (A) Incidence of cognitive impairment in CMBs versus non-CMBs patients. (B) Cognitive assessment score of CMBs versus non-CMBs patients.
Figure 3
Figure 3
Meta-analysis of incidence of cognitive impairment in CMBs versus non-CMBs.
Figure 4
Figure 4
Meta-analysis of cognitive assessment score in CMBs versus non-CMBs based on MMSE and MoCA.
Figure 5
Figure 5
Meta-analysis of number of CMBs effecting the cognitive impairment.
Figure 6
Figure 6
Meta-analysis of cognitive assessment score based on different locations of CMBs.

References

    1. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74. - PMC - PubMed
    1. Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain. 2004;127:2265–75. - PubMed
    1. Charidimou A, Werring DJ. Cerebral microbleeds and cognition in cerebrovascular disease: an update. J Neurol Sci. 2012;322:50–55. - PubMed
    1. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672–713. - PMC - PubMed
    1. Neuropathology Group, Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) Lancet. 2001;357:169–75. - PubMed

Publication types